Trimethylamine N-oxide is associated with coronary atherosclerotic burden in non-ST-segment myocardial infarction patients: SZ-NSTEMI prospective cohort study

Trimethylamine N-oxide is associated with coronary atherosclerotic burden in non-ST-segment myocardial infarction patients: SZ-NSTEMI prospective cohort study

Trimethylamine N-oxide (TMAO) is reported to accelerate atherosclerosis and the development of adverse cardiac outcomes. Relationship between coronary atherosclerotic burden and TMAO has been examined in stable coronary artery disease and ST-segment elevation myocardial infarction, but not in non...

Full description

Bibliographic Details
Main Authors: Khalid Bin Waleed, Gary Tse, Yong-Kang Lu, Chang-Nong Peng, Hong Tu, Li-Gang Ding, Yun-Long Xia, Shu-Lin Wu, Xin-Tao Li, Hou-Qing Zhou, Qi-Ying Chen, Ai-Mei Sun, Afrasyab Altaf, Jun-Lei Chang, Li-Li Wang
Format: Article
Language:English
Published: IMR (Innovative Medical Research) Press Limited 2021-03-01
Series:Reviews in Cardiovascular Medicine
Subjects:
trimethylamine n-oxide
non-st-segment elevation myocardial infarction
coronary atherosclerotic burden
syntax score
gensini score
multivessel disease
Online Access:https://rcm.imrpress.com/fileup/2153-8174/PDF/1617068761492-2129141870.pdf

Internet

https://rcm.imrpress.com/fileup/2153-8174/PDF/1617068761492-2129141870.pdf

Similar Items